India, March 10 -- Zydus Lifesciences Limited has secured final approval from the U.S. Food and Drug Administration (USFDA) to manufacture and market Ketoconazole Shampoo, 2% (a generic version of Nizoral® Shampoo, 2%).
Ketoconazole Shampoo is an antifungal medication used to treat dandruff, fungal infections, and other skin conditions. The product will be manufactured at Zydus' topical manufacturing facility in Changodar, Ahmedabad.
As per IQVIA MAT data (January 2025), the annual sales of Ketoconazole Shampoo 2% in the U.S. market were approximately USD 68.89 million.
With this latest approval, Zydus now has 418 USFDA approvals and has filed 483 ANDAs since initiating the filing process in FY 2003-04.
Published by HT Digital Conte...